Brief: Willow Biosciences Announces Commercial Transition And Focus On Biooxi Platform
Aug 24 (Reuters) -
* WILLOW BIOSCIENCES ANNOUNCES COMMERCIAL TRANSITION AND
FOCUS ON
BIOOXI PLATFORM
* WILLOW BIOSCIENCES INC - REDUCING SIZE OF ITS BOARD FROM
NINE TO
FIVE MEMBERS
Source text for Eikon: ID:nCNWJZNkqa
Further company coverage: WLLW.TO
((reuters.briefs@thomsonreuters.com;))
Recent news on Atlas Energy
See all newsBrief: Atlas Energy Corp. Announces Appointments To Subsidiary Board And Extension Of Tsxv Sandbox Exit Deadline
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Reports Second Quarter 2025 Financial Results
Brief: Atlas Energy Strengthens Leadership Team With Appointment Of Andy Duncan As Senior Executive
Brief: Willow Biosciences Announces Completion Of Transformative Recapitalization Transactions To Form Atlas Energy Corp